Most Clicked StoriesMore >


CMS withdraws planned limits on hospice drugs in U.S.

PCMA SmartBrief | Jul 21, 2014

The CMS pulled its proposed restrictions of private insurance coverage for hospice drugs under Medicare because they were blocking some terminally ill patients' access to drugs. Prior approval for coverage of anxiety drugs, laxatives, anti-nauseants and analgesics will now be required. "Based on discussions with stakeholders, we are adjusting our rules so that beneficiaries enrolled in hospice will continue to have access to their medications," said CMS spokesman Raymond Thorn. Reuters (07/18) Hill, The (07/18)


Ore. hopes to cut deal on hepatitis C drug prices

PCMA SmartBrief | Jul 18, 2014

Medicare Part D plans pay less than Medicaid, DOD

PCMA SmartBrief | Jul 22, 2014

Federal court says tax credits are illegal for plans bought on HealthCare.gov

PCMA SmartBrief | Jul 22, 2014

Drug prices can go down with restrictive formularies

PCMA SmartBrief | Jul 18, 2014

Is Sovaldi overpriced?

PCMA SmartBrief | Jul 22, 2014

Expensive new drugs tax American budgets

PCMA SmartBrief | Jul 17, 2014

PCMA: Drugstore lobby pushes legislation undermining cost-saving pharmacy networks

PCMA SmartBrief | Jul 23, 2014

Personalized medicine's high cost exemplified by Kalydeco's $300,000 price

PCMA SmartBrief | Jul 21, 2014

UnitedHealth Group will offer plans on some exchanges

PCMA SmartBrief | Jul 18, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more